Related Experiment Videos
Autosomal recessive polycystic kidney disease
1Hospital for Sick Children, London, UK.
Pediatric Nephrology (Berlin, Germany)
|January 1, 1989
Summary
Autosomal recessive polycystic kidney disease (ARPCKD) shows an improved prognosis. Survival rates are higher than previously assumed, with significant improvements noted in long-term outcomes for affected children.
Area of Science:
- Nephrology
- Pediatric Nephrology
- Medical Genetics
Background:
- Autosomal recessive polycystic kidney disease (ARPCKD) is a severe genetic disorder.
- Historically, ARPCKD has been associated with a poor prognosis and high infant mortality.
- Understanding the clinical spectrum and outcomes is crucial for patient management.
Purpose of the Study:
- To review the clinical features and outcomes of patients with ARPCKD.
- To determine survival rates and identify factors influencing prognosis.
- To assess the current outlook for ARPCKD compared to historical data.
Main Methods:
- Retrospective review of 55 clinical cases of ARPCKD.
- Analysis of patient demographics, clinical presentation, and treatment interventions.
- Life-table survival analysis from birth and from one year of age.
Main Results:
- 45% of patients presented under 1 month of age; hyponatremia was common in infants.
- Hypertension (65%) and splenomegaly (47%) were significant clinical findings.
- Life-table survival rates: 86% at 3 months, 79% at 1 year, 51% at 10 years, and 46% at 15 years from birth.
Conclusions:
- The prognosis for ARPCKD has improved, contrary to previous assumptions.
- Survival rates are significantly better, especially for patients surviving the first year.
- Early presentation and specific clinical features like hyponatremia require close monitoring.